- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01637337
Laparoscopic Pyelolithotomy Versus Percutaneous Nephrolothotomy for Management of >3cm Renal Pelvis Stone
April 19, 2016 updated by: Alireza Aminsharifi, Shiraz University of Medical Sciences
To compare the outcome of laparoscopic pyelolithotomy with percutaneous nephrolithotomy in patients with >3cm renal pelvis stone.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Fars
-
Shiraz, Fars, Iran, Islamic Republic of, 71344
- Shiraz University of Medical Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adults with >3cm renal pelvis stone
Exclusion Criteria:
- History of previous surgery on the target kidney
- Active UTI
- Coagulopathy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: laparoscopic pyelolithotomy
|
laparoscopy
|
|
Sham Comparator: percutaneous nephrolithotomy
|
percutaneous nephrolithotomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Stone free rate
Time Frame: at least 6 month after surgery
|
at least 6 month after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2012
Primary Completion (Actual)
December 1, 2012
Study Completion (Actual)
January 1, 2013
Study Registration Dates
First Submitted
July 3, 2012
First Submitted That Met QC Criteria
July 10, 2012
First Posted (Estimate)
July 11, 2012
Study Record Updates
Last Update Posted (Estimate)
April 20, 2016
Last Update Submitted That Met QC Criteria
April 19, 2016
Last Verified
April 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- 89-01-01-2391
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Renal Pelvis Stone >3cm
-
Peking University First HospitalRecruiting
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedStage III Renal Pelvis Cancer AJCC v8 | Stage III Ureter Cancer AJCC v8 | Stage IV Renal Pelvis Cancer AJCC v8 | Stage IV Ureter Cancer AJCC v8 | Stage III Renal Pelvis and Ureter Cancer AJCC v8 | Stage IV Renal Pelvis and Ureter Cancer AJCC v8 | Stage 0a Renal Pelvis and Ureter Cancer AJCC v8 | Stage... and other conditionsUnited States
-
Steba Biotech S.A.PrimeVigilance; ICON plcRecruitingTransitional Cell Cancer of Renal Pelvis and UreterUnited States, Spain, Israel, Germany, France
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Alrijne HospitalCompletedKidney Diseases | Urologic Diseases | Kidney Calculi | Urinary Calculi | Urolithiasis | Stone Ureter | Stone, Kidney | Urinary Stone | Pyelonephritis | Hydronephrosis | Obstruction | Kidney Failure, Acute | Ureter Obstruction | Urinary Obstruction | Kidney Dysfunction | Kidney Insufficiency | Pyelonephritis Acute | Stone, Urinary and other conditionsNetherlands
-
University of Alabama at BirminghamBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedUrothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer)United States
-
Alliance for Clinical Trials in OncologyRecruitingClear Cell Renal Cell Carcinoma | Stage III Renal Pelvis Cancer AJCC v8 | Renal Cell Carcinoma (RCC) | Stage II Renal Pelvis Cancer AJCC v8United States
-
Ankara City Hospital BilkentCompletedRenal Stone | Ureter Stone | Kidney; Complications | Renal OxygenationTurkey
-
Wake Forest University Health SciencesCogenix Medical CorporationWithdrawnKidney Stone | Renal Stone | Ureter StoneUnited States
-
University of British ColumbiaRecruitingTransitional Cell Cancer of the Renal Pelvis and Ureter | Urothelial Carcinoma of the Renal Pelvis and UreterCanada
-
Ain Shams UniversityCompletedPercutaneous Nephrolithotomy (PCNL) | Renal Stone DiseaseEgypt
Clinical Trials on laparoscopic pyelolithotomy
-
Damascus UniversityCompletedLarge Renal StoneSyrian Arab Republic
-
Zealand University HospitalCompleted
-
University of AthensUnknownCholecystectomy, LaparoscopicGreece
-
KANAN ISMAYILZADA, MDCompleted
-
University Hospital, GrenobleCompleted
-
Ain Shams UniversityRecruiting
-
Chung Shan Medical UniversityActive, not recruitingPelvic Organ Prolapse | Pelvic Organ Prolapse Vaginal Surgery | Sacrocolpopexy | PectopexyTaiwan
-
Oxford University Hospitals NHS TrustCompletedGastroesophageal Reflux DiseaseUnited Kingdom
-
Hospital Universitari Vall d'Hebron Research InstituteFundación Mutua MadrileñaCompletedOvarian Neoplasms | Endometrial NeoplasmsSpain
-
The Cleveland ClinicTerminatedRectal Prolapse | ProcidentiaUnited States